Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus

DNA vaccines offer promising strategies for immunization against infections. However, their clinical use requires improvements in immunogenicity. We explored the efficacy of Toll-like receptor (TLR) ligands (TLR-Ls) on augmenting the immunogenicity of a DNA prime–modified vaccinia virus Ankara (MVA)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kwissa, Marcin, Amara, Rama R., Robinson, Harriet L., Moss, Bernard, Alkan, Sefik, Jabbar, Abdul, Villinger, Francois, Pulendran, Bali
Formato: Artigo
Idioma:Inglês
Publicado: The Rockefeller University Press 2007
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2118478/
https://ncbi.nlm.nih.gov/pubmed/17954572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20071211
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares